This programme is unique as it combines the study of pharmaceutical technology, including pharmaceutical sciences, and medicines control.

Exciting new opportunities for chemical intervention in disease have emerged based on a greater understanding of the molecular aspects of disease progression. Drug discovery combines the expertise of medicinal chemists required in translating the understanding of the molecular aspects of disease progression to the identification of suitable chemical entities, and the process of optimisation that ultimately leads to the discovery of new medicines.

This is an exciting time to be involved in cancer therapeutics. Based upon a greater understanding of the molecular aspects of cancer, new opportunities for therapeutic intervention have emerged that are effectively ‘target orientated’. These new therapeutics are quite distinct from the classical chemotherapeutic agents and they offer the prospect of truly selective cancer therapies that are tailored towards the individual patient’s tumour. Cancer pharmacology plays a key role in drug development. In both the laboratory and the clinic, cancer pharmacology has had to adapt to the changing face of drug development by establishing experimental models and target orientated approaches.

This full-time Master’s programme provides a comprehensive overview of drug safety practices within the drug development process.